Vasculitis Trial, Recruiting NCT06824714 Sponsor: Nanjing Medical University Condition: Vasculitis
Back to Vasculitis

Vasculitis Trial, Recruiting

NCT06824714
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been suspected of having or confirmed to have large vessel vasculitis (a condition where the body's large blood vessels become inflamed), and you are willing to have a PET/MRA scan (a type of imaging scan that combines two scanning methods)
  • You are willing and able to attend follow-up appointments over a longer period of time
  • You are willing to sign a consent form agreeing to take part in the study

Who may not be able to join:

  • You have other serious heart, blood vessel, or brain conditions, cancer, a serious infectious disease, or severely reduced kidney function
  • You have a severe mental health condition, or severe claustrophobia (fear of enclosed spaces) that would make it difficult to go through the scan
  • You have certain medical devices or metal implants in your body, such as a heart pacemaker, artificial heart valve, certain surgical clips on blood vessels, an aneurysm clip, a cochlear implant, an insulin pump or similar medication device, metal bone plates or screws, artificial joints, an electronic eye, or an artificial eye (confirm with trial site if unsure whether your device or implant is included)
  • You are allergic to contrast dye (a substance sometimes used during scans to make images clearer)
  • You are pregnant or currently breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +86 15951871668

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Nanjing Medical University
Registry
ClinicalTrials.gov
Start date
1 January 2024
Est. completion
1 January 2028

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Vascular structural progression

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov